pharma · Alopecia areata · Multiple myeloma
First Biotech (Australia)
Pfizer Australia Pty Ltd
Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosi
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
- Founded
- 2017
- Employees
- 2
- Programs
- 126
- Drugs
- 208
- Patents
- 0
B7981118
Phase 2 · small molecule · CHRONIC SPONTANEOUS URTICARIA
B7981118 for CHRONIC SPONTANEOUS URTICARIA is a Phase 2 program (small_molecule) at Pfizer Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code B7981118
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pfizer Australia Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- CHRONIC SPONTANEOUS URTICARIA
- Status
- active
- Trials
- 1